B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+4.41%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.06B
AUM Growth
+$3.06B
(+0.94%)
Cap. Flow
-$84M
Cap. Flow
% of AUM
-2.74%
Top 10 Holdings %
Top 10 Hldgs %
37.02%
Holding
99
New
15
Increased
19
Reduced
16
Closed
14
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$46M |
| 2 |
Boston Scientific
BSX
|
$38.8M |
| 3 |
Viridian Therapeutics
VRDN
|
$28.7M |
| 4 |
Maravai LifeSciences
MRVI
|
$22.4M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$20.5M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$90.4M |
| 2 |
Glaukos
GKOS
|
$54.3M |
| 3 |
Amgen
AMGN
|
$39M |
| 4 |
Intuitive Surgical
ISRG
|
$34M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$29.7M |
Sector Composition
| 1 | Healthcare | 54.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $88M | 2.88% | 933,362 +166,562 | +22% | +$15.7M |
|
2
Vaxcyte
PCVX
$4B
| $86M | 2.81% | 1,722,353 +402,375 | +30% | +$20.1M |
|
3
Align Technology
ALGN
$10.3B
| $79.2M | 2.59% | 224,030 +16,900 | +8% | +$5.98M |
|
|
4
Glaukos
GKOS
$5.5B
| $74.4M | 2.43% | 1,044,392 -762,259 | -42% | -$54.3M |
|
5
Xenon Pharmaceuticals
XENE
$2.98B
| $70.4M | 2.3% | 1,828,353 -308,757 | -14% | -$11.9M |
|
6
Natera
NTRA
$23.1B
| $56.1M | 1.83% | 1,152,851 +170,610 | +17% | +$8.3M |
|
|
DCPH
7
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $51.3M | 1.68% | 3,646,419 +405,068 | +12% | +$5.7M |
|
8
iRhythm Technologies
IRTC
$5.46B
| $49.9M | 1.63% | 478,557 +24,388 | +5% | +$2.54M |
|
|
DICE
9
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $47.8M | 1.56% | 1,029,901 +45,101 | +5% | +$2.1M |
|
|
10
Keros Therapeutics
KROS
$618M
| $46M | 1.5% | +1,143,865 | New | +$46M |
|
|
NVRO
11
DELISTED
NEVRO CORP.
NVRO
| $45.2M | 1.48% | 1,776,368 +143,453 | +9% | +$3.65M |
|
|
12
Intuitive Surgical
ISRG
$170B
| $42.3M | 1.38% | 123,820 -99,300 | -45% | -$34M |
|
13
Merus
MRUS
$4.98B
| $40.6M | 1.33% | 1,543,162 +70,078 | +5% | +$1.85M |
|
14
Day One Biopharmaceuticals
DAWN
$769M
| $40.1M | 1.31% | 3,361,813 +201,918 | +6% | +$2.41M |
|
|
15
Boston Scientific
BSX
$156B
| $38.8M | 1.27% | +717,050 | New | +$38.8M |
|
16
Legend Biotech
LEGN
$6.41B
| $38.4M | 1.25% | 556,301 -45,500 | -8% | -$3.14M |
|
|
FNA
17
DELISTED
Paragon 28, Inc.
FNA
| $37.9M | 1.24% | 2,136,122 +1,037,400 | +94% | +$18.4M |
|
18
Biogen
BIIB
$19.4B
| $34.7M | 1.14% | 121,942 -98,800 | -45% | -$28.1M |
|
19
OrthoPediatrics
KIDS
$536M
| $33.4M | 1.09% | 761,208 -237,663 | -24% | -$10.4M |
|
20
Outset Medical
OM
$247M
| $31.9M | 1.04% | 1,460,368 -293,982 | -17% | -$6.43M |
|
21
Aclaris Therapeutics
ACRS
$209M
| $30.1M | 0.98% | 2,901,194 -367,900 | -11% | -$3.82M |
|
|
AXNX
22
DELISTED
Axonics, Inc. Common Stock
AXNX
| $29M | 0.95% | 573,791 +407,087 | +244% | +$20.5M |
|
|
23
Viridian Therapeutics
VRDN
$1.5B
| $28.7M | 0.94% | +1,206,300 | New | +$28.7M |
|
24
Krystal Biotech
KRYS
$4.27B
| $28.3M | 0.93% | 241,399 -106,637 | -31% | -$12.5M |
|
25
Immunocore
IMCR
$1.62B
| $28.1M | 0.92% | 468,027 +41,917 | +10% | +$2.51M |
|